Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
Ivenix
Ivenix Appoints John Douglass as Board of Directors Executive Chair
February 25, 2019 -
PR Newswire
Humana and PatientPing Announce Agreement to Improve Care Coordination for Members Across North Carolina
February 20, 2019 -
PR Newswire
Modis Therapeutics Announces that MT1621 Receives Breakthrough Therapy Designation from FDA for the Treatment of TK2 Deficiency
February 19, 2019 -
PR Newswire
Innovent Announces a Collaboration with Chipscreen Biosciences to Evaluate the Combination Therapy in Colorectal Cancer Patients
February 17, 2019 -
GlobeNewswire
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL747 for Alzheimer’s Disease
February 15, 2019 -
PR Newswire
Innovent Announces First Patient Dosed in a Phase I Clinical Trial of an Anti-OX40 Antibody
February 13, 2019 -
Business Wire
Caribou Biosciences Announces Expansion of Scientific Advisory Board
February 12, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Acceptance of Late-Breaking Abstracts of OTL-101 for ADA-SCID and OTL-102 for X-CGD at the 2019 Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR
February 6, 2019 -
Globe Newswire
Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388
February 4, 2019 -
GlobeNewswire
Hua Medicine Initiates First Combination Study of Dorzagliatin with a DPP-4 Inhibitor in the United States
February 1, 2019 -
PR Newswire
2019 Best in KLAS Report Ranks Protenus No. 1 in Patient Privacy Monitoring
January 31, 2019 -
Business Wire
VitalWare™ Achieves #1 in KLAS Revenue Cycle – Chargemaster Management Category for 2019
January 31, 2019 -
Center for Biosimilars
Innovent Seeks Chinese Regulatory Approval for Proposed Biosimilar Bevacizumab
January 31, 2019 -
GlobeNewswire
Menlo Therapeutics Announces Late-Breaking Oral Presentation at the American Academy of Dermatology Annual Meeting
January 30, 2019 -
PR Newswire
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
January 28, 2019 -
GlobeNewswire
Acacia Pharma Announces Supportive Cardiac Safety Data for BARHEMSYS™
January 23, 2019 -
Pipeline Review
Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of Transfusion-Dependent Beta-Thalassemia in Nature Medicine
January 22, 2019 -
Equity Bulls
Caplin Steriles gets INR 218 crore investment from Eight Roads Ventures and F-Prime Capital
January 18, 2019 -
PR Newswire
NextLevel Health Partners, Inc., Announces Partnership With PatientPing To Improve Member Care And Coordination
January 17, 2019 -
PR Newswire
Promentis Pharmaceuticals Announces Commencement of Phase 2 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism
January 17, 2019 -
Business Wire
Precision BioSciences Announces Formation of Scientific Advisory Board with Anderson, Kantarjian, Schinazi and Turtle
January 16, 2019 -
Baltimore Business Journal
Protenus to expand, move HQ to Brown’s Wharf in Fells Point
January 15, 2019 -
Market Wired
Menlo Therapeutics’ Serlopitant Granted Breakthrough Therapy Designation by FDA for the Treatment of Pruritus Associated with Prurigo Nodularis
January 15, 2019 -
Parkinson's News Today
Sirion and Denali Collaborating to Develop Gene Therapies for Neurodegenerative Diseases
January 14, 2019 -
PR Newswire
Innovent Announces First Patient Dosed in a Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody
January 14, 2019 -
Fierce Biotech
Orchard Therapeutics’ 2019: Pipeline progress, breaking ground on its $90M manufacturing site
January 11, 2019 -
Boston Business Journal
Health software startup PatientPing plans to hire 100, doubling size in 2019
January 11, 2019 -
PR Newswire
Sana Biotechnology Launches Focusing on Engineering Cells to Create a New Class of Medicines
January 4, 2019 -
PR Newswire
Avidity Biosciences’ Arthur A. Levin Publishes Review of Therapeutic Approaches of Targeting RNA in the New England Journal of Medicine
January 3, 2019 -
PR Newswire
Mercy Health Network Partners with PatientPing to Improve Transitions of Care Across Iowa
January 3, 2019 -
Citizen Tribune
Precision BioSciences Appoints Rare Disease Executive Shalini Sharp to Its Board of Directors
December 20, 2018 -
Business Wire
CynergisTek and Protenus Join Forces as Partners to Protect Patient Privacy
December 20, 2018 -
Globe Newswire
Cytek Biosciences Ships 100th Advanced Flow Cytometry System
December 20, 2018 -
Business Wire
Compass Therapeutics Expands Leadership Team with Appointments of Chief Medical Officer and Chief Financial Officer
December 19, 2018 -
Business Wire
Semma Therapeutics Expands Executive Leadership Team
December 18, 2018 -
Carestack
CareStack® Announces Partnership with DentalXChange to Help Dental Practices Speed Claims Processing and Enhance Administrative Workflows
December 17, 2018 -
PRNewswire
Devoted Health Expands Provider Network With Top Hospitals in Lakeland Area
December 17, 2018 -
PRNewswire
Innovent and Incyte Announce Strategic Collaboration and Licensing Agreement for Three Clinical-stage Product Candidates in China
December 16, 2018 -
Business Insider
VitalWare™ Introduces HospitalPriceIndex.com In Response To Governmental Pricing Transparency Mandate
December 14, 2018 -
B3C Newswire
Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
December 14, 2018 -
Nasdaq
Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California
December 13, 2018 -
Business Wire
Caribou Biosciences Appoints Dr. Natalie Sacks to Board of Directors
December 12, 2018 -
Business Wire
Checkmate Pharmaceuticals Announces CEO Transition and $22 Million Financing
December 12, 2018 -
PRNewswire
Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints
December 12, 2018 -
Globe Newswire
Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis
December 10, 2018 -
Market Screener
Genomics plc Announces second close of Series B financing, raising a further £8m, bringing the total round to £33m
December 10, 2018 -
Globe Newswire
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinson’s Disease
December 10, 2018 -
Business Wire
Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space
December 6, 2018 -
Globe Newswire
Unum Therapeutics Inc. (UMRX) Secures U.S. Patent for ACTR Technology
December 6, 2018 -
Globe Newswire
Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting
December 5, 2018 -
Biospace
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-OX40 Monoclonal Antibody IBI101
December 5, 2018 -
Business Wire
Turnstone Biologics Unveils Novel Vaccinia Oncolytic Viral Immunotherapy Platform
November 30, 2018 -
BC Extra
Chi-Med, Innovent Enter Global Cancer Partnership
November 30, 2018 -
PRNewswire
Innovent Announces Global Collaboration with Hutchison MediPharma to Evaluate Combination of Sintilimab and Fruquintinib in Solid Tumors
November 29, 2018 -
Business Wire
Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy
November 27, 2018 -
PRNewswire
Blue Cross Blue Shield of Massachusetts Expands Medicare Network to Include Iora Health
November 20, 2018 -
PRNewswire
TraceLink Achieves 55% Overall Revenue Growth for Q3 2018
November 19, 2018 -
PRNewswire
Promentis Pharmaceuticals Announces Successful Completion of Phase 1 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism
November 16, 2018 -
CareStack® Partners with Callpop to Expand Patient Communication Capabilities for Dental Practices Nationwide
November 14, 2018 -
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
November 14, 2018 -
PRNewswire
Zeel Partners With Stride Health To Bridge Insurance Gap For Massage Therapists
November 14, 2018 -
Globe Newswire
Cytek Biosciences Continues Momentum by Strengthening Executive Team, Adding Board Members
November 13, 2018 -
Tempest Therapeutics Reports Proof of Mechanism Data for First-in-Class PPAR Alpha Antagonist
November 13, 2018 -
Modis Therapeutics Announces Prime Designation Granted by the European Medicines Agency to MT1621 for the Treatment of TK2 Deficiency
November 13, 2018 -
PRNewswire
NMPA Accepts Biosimilar New Drug Application for IBI303, a Biosimilar Candidate to Humira(R) (adalimumab)
November 12, 2018 -
Globe Newswire
Unum Therapeutics to Present Preclinical Data on Applications of ACTR Proprietary Technology Platform in Solid Tumors at the San Antonio Breast Cancer Symposium
November 9, 2018 -
Innovent Highlights Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line Squamous NSCLC
November 9, 2018 -
B3C Newswire
Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations
November 8, 2018 -
PRNewswire
Maine’s Northern Light Beacon Health Partners with PatientPing to Coordinate Care for Patients Throughout the State — and Beyond
November 6, 2018 -
Globe Newswire
Unum Therapeutics to Present Preclinical Data on a New, Emerging Platform Technology for Solid Tumors at the SITC Annual Meeting
November 6, 2018 -
Business Wire
Health First Selects Kyruus Solutions to Enable Digital Patient Access Initiatives
November 6, 2018 -
Business Wire
Health First Selects Kyruus Solutions to Enable Digital Patient Access Initiatives
November 6, 2018 -
Business Wire
Compass Therapeutics Announces Preclinical Data on Lead Antibody Program and NK Cell Engager Platform to be Presented at the Society for Immunotherapy of Cancer Annual Meeting
November 6, 2018 -
B3C Newswire
Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option
November 5, 2018 -
Globe Newswire
Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases
November 1, 2018 -
PRNewswire
PatientPing Expands Care Coordination Offering to Help Organizations Succeed Under BPCI Advanced
November 1, 2018 -
Reuters
China’s Innovent Biologics Makes 5 Percent Gain in Hong Kong Debut
October 31, 2018 -
PRNewswire
Adagene Announces First Patient Dosed in United States and Acceptance of IND in China for ADG-106
October 31, 2018 -
Globe Newswire
Orchard Therapeutics Announces Pricing of Initial Public Offering
October 30, 2018 -
Innovent Biologics Raises $421 Million in Hong Kong IPO
October 25, 2018 -
Globe Newswire
Cytek Biosciences Debuts Advanced Flow Cytometry System that Breaks the Cost Barrier
October 23, 2018 -
Business Wire
Kyruus Announces Launch of ProviderMatch for Salesforce on the Salesforce AppExchange to Help Health Systems Deliver Optimal Access Experience
October 23, 2018 -
Gene therapy biotech Orchard Therapeutics sets terms for $200 million IPO
October 23, 2018 -
PRNewswire
US HealthVest is Developing a New Behavioral Hospital on Hendricks Regional Health Plainfield Campus
October 17, 2018 -
Devoted Health, New Medicare Advantage Business, Raises $300 Million
October 16, 2018 -
PRNewswire
TraceLink Announces Availability of End-to-End DSCSA Saleable Returns Verification Solution for Pharmaceutical Manufacturers and Wholesale Distributors
October 16, 2018 -
PRNewswire
PatientPing’s National Community of ACO Providers Generate More than $270 Million in Shared Savings
October 10, 2018 -
Business Wire
Buoy Health Named to CNBC’s 2018 Upstart 100 List Highlighting Innovation and Rapid Growth
October 9, 2018 -
PRNewswire
FAREVA Selects TraceLink to Comply with EU FMD Regulations
October 8, 2018 -
Orchard Therapeutics plans $172.5 million U.S. IPO
October 5, 2018
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.